Lupus (SLE) trials in China

In China 163 Also abroad 354

163 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
Where
Beijing
Age
18 years to 65 years
People
44
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06980597
Phase 1Not yet taking people in China
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
Where
Changzhou
Age
18 years and over
People
18
Run by
Changzhou No.2 People's Hospital
See details and how to joinNCT06978738
Early phase 1Not yet taking people in China
Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Where
Suzhou
Age
18 years and over
People
15
Run by
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT06970951
Early phase 1Taking people
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus
Where
Hangzhou
Age
18 years and over
People
18
Run by
Zhejiang University
See details and how to joinNCT06920433
Early phase 1Taking people
An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus
Where
Shanghai
Age
18 years to 65 years
People
36
Run by
Changhai Hospital
See details and how to joinNCT06010472
Phase 1Taking people
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE
Where
Hangzhou
Age
5 years and over
People
18
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06934447
Phase 1Not yet taking people in China
An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus Erythematosus
Where
Wuhan
Age
18 years to 75 years
People
19
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06945068
No phaseTaking people
An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
Where
Changsha
Age
18 years and over
People
18
Run by
The First Affiliated Hospital of University of Science and Technology of China
See details and how to joinNCT06503224
No phaseTaking people
Chinese Rheumatism Biobank(CRB)
Where
Beijing
People
300
Run by
Chinese SLE Treatment And Research Group
See details and how to joinNCT06887517
Phase 2Taking people
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Where
Beijing
Age
18 years to 65 years
People
50
Run by
Peking University People's Hospital
See details and how to joinNCT06794008
Phase 3Taking people
Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children
Where
Guangzhou
Age
6 years to 18 years
People
50
Run by
Guangzhou Women and Children's Medical Center
See details and how to joinNCT06904729
No phaseTaking people
Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
Where
Wuhan
Age
18 years and over
People
6
Run by
Tongji Hospital
See details and how to joinNCT06902844
Phase 1Taking people
CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus
Where
Wuhan
Age
18 years to 70 years
People
20
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06349343
Phase 2Not yet taking people in China
Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)
Where
Beijing, Bengbu, Changchun, Changsha, Chengdu, Guangzhou, Hefei, Jinan, Kunming, Langfang, Lanzhou, Meihekou, Mianyang, Nanchang, Nanjing, Nanning, Pu'er, Puyang, Shanghai, Shaoyang, Shenyang, Shenzhen, Shijiazhuang, Shiyan, Suzhou, Taiyuan, Taizhou, Tianjin, Wenzhou, Wuhan, Xi'an, Xi’an, Zhengzhou
Age
18 years to 70 years
People
120
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06859931
Phase 1/2Taking people
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
Where
Beijing, Changchun, Guangzhou, Hangzhou, Jiujiang, Kunming, Linfen, Mianyang, Nanchang, Pingxiang, Taiyuan, Xiamen, Xinxiang
Age
18 years to 75 years
People
168
Run by
Sinocelltech Ltd.
See details and how to joinNCT06841042
Phase 2Not yet taking people in China
Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
Where
Beijing
Age
18 years to 65 years
People
150
Run by
Keymed Biosciences Co.Ltd
See details and how to joinNCT06791772
Early phase 1Taking people
CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis
Where
Hangzhou
Age
18 years and over
People
9
Run by
He Huang
See details and how to joinNCT06785519
Phase 1/2Taking people
A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
Where
Wuhan
Age
18 years to 70 years
People
15
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06106893
Phase 1/2Taking people
A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus
Where
Wuhan
Age
18 years to 70 years
People
15
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06106906
No phaseTaking people
Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
Where
Beijing
Age
18 years and over
People
5,000 worldwide
Run by
Monash University
See details and how to joinNCT03138941
No phaseEnrolling by invitation
Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases
Where
Shanghai
Age
18 years to 65 years
People
15
Run by
Bioray Laboratories
See details and how to joinNCT05859997
Phase 1Taking people
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
Where
Hangzhou
Age
5 years and over
People
18
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06691152
No phaseTaking people
High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)
Where
Guangzhou
Age
14 years and over
People
5,000
Run by
First Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT06682507
Phase 1/2Taking people
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Where
Beijing
Age
21 years to 90 years
People
60
Run by
Essen Biotech
See details and how to joinNCT06428188
Phase 1/2Taking people
JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
Where
Kunming
Age
14 years to 75 years
People
20
Run by
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
See details and how to joinNCT06675422